Imatinib- and Nilotinib-Induced Lichenoid Eruption in Chronic Myeloid Leukemia: A Rare Case Report

Imatinib and nilotinib are inhibitors of tyrosine kinases (TKIs) generated from the bcr-abl fusion protein, c-Kit, and platelet-derived growth factor receptors. Cutaneous adverse effects (AEs) of TKI are the most frequent non-hematological sequelae. In our case, the common molecular target raises th...

全面介紹

書目詳細資料

發表在:	Indian Dermatology Online Journal
Main Authors:	Meenakshi Sachdeva, Jayanti Singh, Surabhi Dayal, Aanchal Gupta
格式:	Article
語言:	英语
出版:	Wolters Kluwer Medknow Publications 2023-10-01
主題:	chronic myeloid leukemia cross-intolerance lichenoid eruption tyrosinase kinase inhibitors
在線閱讀:	https://journals.lww.com/10.4103/idoj.idoj_229_23